Concepedia

Mark J. Axelrod

MJ

Statistics

Publications

8

Citations

454

H-Index

8

Active since

2005

Affiliations

University of Virginia(Current)

George Mason University

Gilead Sciences (United States)

Mark J. Axelrod is an author at University of Virginia specializing in systems biology, tumor biology, and tumor microenvironment.

Top concepts

Publications per year

2005–2017

8

Publications

8

Hemoglobin conformation couples erythrocyte <i>S</i> -nitrosothiol content to O <sub>2</sub> gradients

Allan Doctor, Ruth Platt, Mary Lynn Sheram et al. · Proceedings of the National Academy of Sciences · 2005 · 205 citations · Full text

Microenvironmental agonists generate de novo phenotypic resistance to combined ibrutinib plus venetoclax in CLL and MCL

Kallesh D. Jayappa, Craig A. Portell, Vicki L. Gordon et al. · Blood Advances · 2017 · 104 citations · Full text

Combinatorial drug screening identifies compensatory pathway interactions and adaptive resistance mechanisms

Mark J. Axelrod, Vicki L. Gordon, Mark R. Conaway et al. · Oncotarget · 2013 · 47 citations · Full text

, , +20

Synthetic Lethal Screening with Small-Molecule Inhibitors Provides a Pathway to Rational Combination Therapies for Melanoma

Devin G. Roller, Mark J. Axelrod, Brian J. Capaldo et al. · Molecular Cancer Therapeutics · 2012 · 34 citations · Full text

Synergistic Cytotoxicity of Ibrutinib and the BCL2 Antagonist, ABT-199(GDC-0199) in Mantle Cell Lymphoma (MCL) and Chronic Lymphocytic Leukemia (CLL): Molecular Analysis Reveals Mechanisms of Target Interactions

Craig A. Portell, Mark J. Axelrod, L. Kyle Brett et al. · Blood · 2014 · 28 citations

1–5 of 8